Göhlmann
Christian Göhlmann, Bruchsal-Untergrombach DE
Patent application number | Description | Published |
---|---|---|
20100121344 | TOOL FOR REMOVING OBJECT FROM THE BODY OF A PATIENT - A tool for removing a discrete object from the body of a human or animal patient includes a single length of Nitinol tubing and a sheath. The tubing includes a tool head section at a distal end of the tubing and a shaft section extending from a proximal end of the tubing to the tool head section. The tool head section includes a slitted section and a non-slitted section. The non-slitted section is disposed at a distal most end of the tubing. The slitted section includes a plurality of longitudinal slits forming a plurality of strands. | 05-13-2010 |
Christian Göhlmann, Bruchsal-Untergrombach DE
Patent application number | Description | Published |
---|---|---|
20100121344 | TOOL FOR REMOVING OBJECT FROM THE BODY OF A PATIENT - A tool for removing a discrete object from the body of a human or animal patient includes a single length of Nitinol tubing and a sheath. The tubing includes a tool head section at a distal end of the tubing and a shaft section extending from a proximal end of the tubing to the tool head section. The tool head section includes a slitted section and a non-slitted section. The non-slitted section is disposed at a distal most end of the tubing. The slitted section includes a plurality of longitudinal slits forming a plurality of strands. | 05-13-2010 |
20120103140 | Tool for Removing Object from the Body of a Patient - A tool for removing a discrete object from the body of a human or animal patient includes a single length of Nitinol tubing and a sheath. The tubing includes a tool head section at a distal end of the tubing and a shaft section extending from a proximal end of the tubing to the tool head section. The tool head section includes a slitted section and a non-slitted section. The non-slitted section is disposed at a distal most end of the tubing. The slitted section includes a plurality of longitudinal slits forming a plurality of strands. | 05-03-2012 |
Hinrich Wilhelm Helmut Göhlmann, S-Hertogenbosch NL
Patent application number | Description | Published |
---|---|---|
20090298874 | BACTERIAL ATP SYNTHASE BINDING DOMAIN - This invention provides an isolated mutant atpE protein and departing from said mutant atpE protein the identification of an ATPase binding domain. This invention also provides related nucleic acids, vectors, host cells, pharmaceutical compositions and articles of manufacture. This invention further provides methods for determining whether a test compound interacts with an atpE protein, i.e. with the ATPase binding domain of the present invention, as well as pharmaceuticals compositions comprising said test compound, in particular as antimicrobials, more particular as antimycobacterial agent, even more particular for treating tuberculosis in a subject. | 12-03-2009 |
Hinrich Wilhelm Helmut Göhlmann, S-Hertogenbosch NL
Patent application number | Description | Published |
---|---|---|
20090298874 | BACTERIAL ATP SYNTHASE BINDING DOMAIN - This invention provides an isolated mutant atpE protein and departing from said mutant atpE protein the identification of an ATPase binding domain. This invention also provides related nucleic acids, vectors, host cells, pharmaceutical compositions and articles of manufacture. This invention further provides methods for determining whether a test compound interacts with an atpE protein, i.e. with the ATPase binding domain of the present invention, as well as pharmaceuticals compositions comprising said test compound, in particular as antimicrobials, more particular as antimycobacterial agent, even more particular for treating tuberculosis in a subject. | 12-03-2009 |
20120219964 | BACTERIAL ATP SYNTHASE BINDING DOMAIN - This invention provides an isolated mutant atpE protein and departing from said mutant atpE protein the identification of an ATPase binding domain. This invention also provides related nucleic acids, vectors, host cells, pharmaceutical compositions and articles of manufacture. This invention further provides methods for determining whether a test compound interacts with an atpE protein, i.e. with the ATPase binding domain of the present invention, as well as pharmaceuticals compositions comprising said test compound, in particular as antimicrobials, more particular as antimycobacterial agent, even more particular for treating tuberculosis in a subject. | 08-30-2012 |